acut
respiratori
infect
ari
respons
consider
morbid
mortal
worldwid
document
respiratori
specimen
help
appropri
clinic
manag
signific
effect
diseas
progress
patient
antimicrobi
therapi
use
risk
secondari
spread
infect
compar
perform
four
commerci
multiplex
kit
use
french
univers
hospit
diagnost
microbiolog
laboratori
detect
ari
pathogen
ie
xtag
respiratori
viral
panel
fast
respifind
smart
clart
pneumovir
fast
track
diagnost
respiratori
pathogen
kit
use
standardis
nucleic
acid
extract
protocol
comprehens
compar
approach
mix
refer
well
establish
realtim
pcr
detect
techniqu
analysi
converg
posit
result
test
respiratori
clinic
sampl
identifi
global
high
degre
correl
least
three
techniqu
xtag
respifind
techniqu
highest
youden
index
yi
posit
predict
ppv
specif
sp
valu
observ
core
test
eg
influenza
acut
respiratori
infect
ari
respons
consider
morbid
mortal
worldwid
precis
rapid
document
respiratori
specimen
lead
signific
effect
diseas
progress
patient
identif
caus
agent
lead
provid
appropri
therapi
administr
also
use
decreas
use
unnecessari
antimicrobi
therapi
limit
risk
secondari
spread
infect
howev
ari
often
associ
poorli
specif
clinic
present
therefor
aetiolog
diagnosi
mainli
reli
laboratori
test
convent
laboratori
diagnost
method
sever
limit
routin
detect
respiratori
pathogen
exampl
cultur
isol
virus
bacteria
poorli
sensit
time
consum
usual
slow
provid
biolog
result
acut
phase
diseas
direct
immunofluoresc
assay
immunochromatograph
antigen
test
provid
result
rapidli
repres
timeand
laborconsum
task
former
poorli
sensit
latter
molecular
biolog
test
allow
detect
varieti
viral
bacteri
pathogen
within
hour
excel
sensit
specif
may
repres
credibl
altern
aforement
biolog
assay
howev
given
number
aetiolog
agent
potenti
implic
ari
convent
monoplex
pcr
assay
tediou
expens
requir
larg
amount
biolog
sampl
consequ
multiplex
molecular
detect
test
increasingli
develop
recent
year
number
commerci
kit
propos
diagnost
microbiolog
laboratori
allow
detect
differ
pathogen
includ
xtag
respiratori
viral
panel
fast
assay
luminex
molecular
diagnost
toronto
canada
filmarray
respiratori
viral
panel
assay
biofir
diagnost
salt
lake
citi
ut
fast
track
diagnost
respiratori
pathogen
assay
fast
track
diagnost
luxembourg
clart
pneumovir
genomica
coslada
spain
respifind
smart
assay
pathofind
maastricht
netherland
esensor
respiratori
viral
panel
genmark
dx
carlsbad
ca
multicodeplx
eragen
bioscienc
easyplex
respiratori
pathogen
kit
ausdiagnost
sydney
australia
seeplex
onestep
ace
detect
pneumobact
ace
detect
seegen
inc
seoul
south
korea
magicplex
rv
panel
realtim
test
seegen
inc
resplex
ii
panel
qiagen
hilden
germani
precis
evalu
multiplex
kit
difficult
absenc
undisput
golden
standard
refer
techniqu
larg
number
pathogen
test
number
studi
compar
detect
molecular
multiplex
platform
inhous
convent
molecular
method
sinc
refer
method
vari
studi
studi
estim
actual
perform
assay
remain
difficult
recent
direct
comparison
commercialis
multiplex
kit
undertaken
refer
inhous
multiplex
realtim
pcr
system
commerci
duplex
pcr
test
followup
pioneer
studi
compar
perform
four
commerci
multiplex
kit
use
french
univers
hospit
diagnost
microbiolog
laboratori
detect
ari
pathogen
ie
xtag
respiratori
viral
panel
fast
respifind
smart
clart
pneumovir
fast
track
diagnost
respiratori
pathogen
kit
analysi
mainli
focuss
viral
pathogen
repres
common
target
kit
number
bacteria
potenti
detect
vari
respifind
smart
fast
track
diagnost
respiratori
pathogen
make
sound
comparison
imposs
combin
normalis
extract
nucleic
acid
refer
monoplex
realtim
pcr
detect
consensu
interpret
algorithm
estim
intrins
capabl
kit
detect
variou
pathogen
test
patient
enrol
copanflufr
cohort
studi
present
ari
influenza
epidem
season
nasopharyng
sampl
avail
patient
select
studi
patient
age
rang
month
year
median
four
commerci
kit
multiplex
detect
respiratori
virus
test
clart
pneumovir
pneumovir
assay
base
pcrdna
microarray
detect
assay
allow
detect
respiratori
virus
fast
track
diagnost
respiratori
pathogen
version
assay
base
multiplex
onestep
revers
transcript
polymeras
chain
reaction
rtpcr
probe
detect
respiratori
pathogen
virus
bacteria
use
biorad
thermocycl
superscript
iii
platinum
onestep
quantit
rtpcr
system
without
rox
invitrogen
xtag
respiratori
viral
panel
fast
xtagrvpf
base
multiplex
rtpcr
reaction
targetspecif
primer
chimer
includ
termin
univers
tag
sequenc
allow
detect
differ
respiratori
virus
sort
luminex
xmap
instrument
respifind
smart
respifind
assay
base
multiplex
ligationdepend
probe
amplif
mlpa
technolog
preced
preamplif
step
result
analys
capillari
electrophoresi
assay
differenti
respiratori
virus
bacteria
one
reaction
melt
curv
analysi
differ
protocol
perform
accord
manufactur
instruct
extract
nucleic
acid
standardis
use
similar
molecular
substrat
assay
one
extract
dedic
test
multiplex
assay
confirm
test
perform
one
ident
aliquot
prepar
nasopharyng
swab
intern
control
test
includ
dedic
extract
final
concentr
adapt
manufactur
recommend
nucleic
acid
extract
use
viru
mini
kit
advanc
xl
biorobot
workstat
qiagen
elut
perform
volum
nucleic
acid
subsequ
store
analysi
combin
system
potenti
allow
detect
respiratori
patho
spectrum
detect
differ
kit
report
tabl
test
allow
detect
respiratori
pathogen
classifi
two
differ
class
core
test
extra
test
core
test
defin
correspond
pathogen
detect
four
kit
firstli
sampl
test
four
broad
rang
multiplex
kit
fig
addit
systemat
test
inf
inf
b
use
inhous
standard
realtim
rtpcr
assay
core
test
inf
inf
b
hrsv
hmpv
ev
hrv
adv
hbov
use
argen
respiratori
multi
well
system
rgene
low
rang
kit
consist
taqmanbas
duplex
pcr
rtpcr
reaction
inf
ab
hrsvhmpv
hrv
evcellular
control
advhbov
sampl
test
neg
given
pathogen
detect
method
propos
neg
pathogen
sampl
test
posit
pathogen
least
differ
techniqu
propos
posit
sampl
discrep
result
posit
one
pathogen
one
detect
method
process
confirm
assay
consist
one
sever
realtim
nest
amplif
protocol
tabl
file
subsequ
declar
posit
neg
accord
result
obtain
posit
predict
valu
ppv
neg
predict
valu
npv
sensit
specif
agreement
evalu
youden
index
valu
calcul
core
test
kit
test
see
secondli
sampl
analys
accord
result
obtain
four
broad
rang
multiplex
kit
extra
test
fig
result
relat
viral
pathogen
analys
depth
sinc
major
bacteri
pathogen
detect
test
decis
tree
similar
use
core
test
design
confirm
techniqu
use
confirm
invalid
discrep
result
tabl
b
file
ppv
sensit
npv
specif
valu
calcul
extra
test
see
compar
perform
kit
sensit
specif
posit
neg
predict
valu
calcul
accord
interpret
rule
decre
previou
section
calcul
reli
follow
definit
true
posit
posit
result
confirm
anoth
kit
confirm
test
ii
fals
posit
posit
result
confirm
anoth
kit
confirm
test
iii
fals
neg
neg
result
invalid
least
kit
kit
confirm
test
iv
true
neg
neg
result
invalid
least
kit
kit
confirm
test
nucleic
acid
extract
describ
use
initi
sampl
volum
elut
volum
tenfold
serial
dilut
nucleic
acid
perform
test
use
relev
inhous
confirm
real
time
pcr
rtpcr
assay
file
last
three
dilut
allow
unambigu
detect
ie
lowest
dilut
ct
highest
dilut
ct
use
creat
panel
subsequ
use
evalu
limit
detect
broad
rang
multiplex
kit
copanflufr
cohort
protocol
approv
french
ethic
committe
de
protect
de
personn
iledefr
septemb
studi
particip
provid
written
inform
consent
analysi
nasopharyng
sampl
use
combin
four
commerci
broad
rang
multiplex
kit
confirm
test
provid
confirm
aetiolog
viral
diagnosi
sampl
includ
sampl
confirm
dual
infect
see
detail
tabl
distribut
confirm
posit
detect
provid
follow
result
enterovirusrhinoviru
influenza
coronaviru
influenza
b
metapneumoviru
respiratori
syncyti
viru
bocaviru
parainfluenzavirus
adenoviru
perform
kit
detect
specif
pathogen
present
tabl
regard
detect
influenza
virus
sensit
pp
valu
rang
respect
pneumovir
kit
kit
regard
influenza
b
best
sensit
observ
respifind
kit
pneumovir
kit
xtagrvpf
kit
pp
valu
kit
except
pneumovir
kit
global
perform
pneumovir
kit
hinder
exist
fals
posit
result
proport
pathogen
test
also
fals
neg
result
common
pathogen
particular
human
rhinovirusesenterovirus
perform
xtagrvpf
kit
hamper
low
sensit
detect
influenza
b
human
bocavirus
human
coronavirus
kit
associ
high
pp
valu
fals
posit
profil
somewhat
similar
kit
exhibit
high
pp
valu
perfect
sensit
detect
influenza
b
parainfluenzavirus
human
respiratori
syncyti
viru
human
rhinovirus
enterovirus
respifind
kit
display
highest
overal
sensit
valu
associ
high
pp
valu
lowest
perform
human
metapneumovirus
sensit
parainfluenzavirus
similar
kit
regard
global
perform
kit
posit
predict
valu
three
four
kit
xtagrvpf
respifind
tabl
highest
overal
specif
observ
kit
score
five
common
pathogen
influenzavirus
b
parainfluenzavirus
human
respiratori
syncyti
virus
human
rhinovirusesenterovirus
import
differ
kit
test
identifi
overal
sensit
rang
pneumovir
kit
respifind
kit
neg
predict
valu
rang
pneumovir
kit
respifind
kit
youden
index
summaris
perform
diagnost
test
global
strong
except
pneumovir
kit
ev
hrv
detect
determin
enteroviru
human
rhinoviru
bacteria
etiolog
identifi
shown
supplementari
inform
tabl
result
present
fig
show
highest
dilut
propos
respifind
kit
detect
pathogen
test
whilst
pneumovir
kit
detect
test
xtagrvpf
kit
detect
test
detect
test
compar
commercialis
multiplex
pcr
techniqu
detect
respiratori
pathogen
use
standardis
nucleic
acid
extract
french
patient
present
ari
studi
mainli
focuss
viral
pathogen
previou
signific
inform
relat
comparison
perform
kit
studi
convent
diagnost
techniqu
includ
direct
immunofluoresc
viral
cultur
homebrew
pcr
case
clart
pneumovir
assay
global
literatur
indic
multiplex
molecular
techniqu
compar
favour
tradit
diagnost
techniqu
least
partial
autom
highli
reproduc
gener
sensit
howev
first
difficult
issu
compar
respiratori
pathogen
multiplex
techniqu
absenc
gold
standard
detect
respiratori
pathogen
refer
abil
techniqu
detect
pathogen
molecular
compon
biolog
sampl
newli
develop
molecular
techniqu
may
sensit
refer
techniqu
ie
fals
posit
refer
refer
techniqu
may
true
posit
detect
refer
method
situat
may
met
new
techniqu
abl
detect
viral
variant
could
detect
previou
method
case
correspond
actual
improv
techniqu
variant
detect
true
pathogen
implic
ari
howev
also
met
new
techniqu
abl
detect
lower
viral
load
actual
clinic
impact
improv
detect
low
viral
load
respiratori
sampl
accur
evalu
medic
signific
acut
phase
ari
obvious
requir
document
altogeth
indic
interpret
evalu
score
remain
care
openmind
accordingli
tri
build
comprehens
approach
comparison
diagnost
kit
mix
refer
well
establishedand
clinic
evaluatedrealtim
pcr
detect
techniqu
includ
current
studi
argen
respiratori
multi
well
system
rgene
low
rang
kit
core
test
use
year
routin
detect
medic
virolog
laboratori
seri
publish
homebrew
techniqu
analysi
converg
posit
result
latter
consid
given
intrins
high
specif
molecular
amplif
techniqu
ii
fact
techniqu
compar
use
differ
technolog
amplif
primer
probabl
obtain
fals
posit
result
two
differ
techniqu
sampl
neglig
evalu
purpos
consequ
sampl
given
pathogen
detect
independ
two
differ
techniqu
declar
posit
pathogen
otherwis
declar
neg
exclud
sampl
wrongli
assign
neg
result
specif
techniqu
perform
better
other
given
pathogen
high
degre
converg
differ
techniqu
suggest
number
fals
neg
result
could
potenti
gener
limit
second
difficult
issu
compar
respiratori
pathogen
multiplex
techniqu
choic
panel
sampl
test
natur
frequenc
pathogen
present
sampl
test
highli
depend
epidemiolog
circumst
popul
test
obviou
influenc
result
analysi
eg
low
number
absenc
posit
sampl
virus
repres
studi
obviou
obstacl
accur
comparison
current
studi
test
patient
ari
age
group
recruit
household
cohort
aim
provid
pictur
french
gener
popul
mean
comparison
previou
hospitalbas
studi
paediatr
popul
underrepres
clinic
present
milder
addit
specif
period
studi
associ
predomin
circul
pandem
variant
influenza
viru
accordingli
low
number
absenc
parainfluenza
viru
human
coronaviru
type
influenza
viru
influenza
c
viru
human
adenoviru
human
parechoviru
infect
allow
signific
comparison
kit
pathogen
import
notic
sinc
previou
studi
low
number
posit
sampl
pathogen
may
conceal
poor
perform
kit
detect
pathogen
eg
case
adenovirus
xtag
respiratori
viral
panel
fast
assay
third
difficult
issu
compar
respiratori
pathogen
multiplex
techniqu
reli
differ
spectra
detect
precis
identif
offer
variou
commercialis
kit
take
aspect
account
identifi
core
test
ie
seri
common
pathogen
detect
kit
inf
inf
b
hrsv
hmpv
ev
hrv
adv
hbov
also
limit
analysi
viral
pathogen
sinc
bacterium
detect
absent
limit
kit
test
simultan
detect
bacteria
virus
repres
theoret
great
advantag
term
clinic
manag
eg
determin
appropri
start
antibiot
treatment
howev
notic
current
studi
bacteria
detect
provid
larg
number
posit
result
potenti
shift
rate
aetiolog
elucid
panel
studi
obvious
deserv
depth
investig
includ
sampl
ari
pair
asymptomat
individu
determin
actual
imput
bacteri
detect
occurr
ari
may
difficult
achiev
qualit
result
clinic
relev
interpret
algorithm
remain
establish
note
detect
low
pathogen
load
may
issu
virus
case
bacteria
specif
difficult
due
frequent
asymptomat
carriag
potenti
pathogen
bacteria
core
test
identifi
import
degre
correl
perform
xtag
respiratori
viral
panel
fast
fast
track
diagnost
respiratori
pathogen
respifind
smart
assay
youden
index
respect
tabl
clart
pneumovir
assay
exhibit
diverg
perform
global
core
test
youden
index
valu
global
core
test
sensit
specif
valu
respect
despit
previou
favour
perform
comparison
homebrew
pcr
techniqu
examin
detail
tabl
sensit
valu
core
test
compar
kit
except
human
rhinovirusesenterovirus
sensit
human
bocavirus
also
trend
exist
fals
posit
result
influenza
metapneumoviru
test
alter
global
posit
predict
valu
kit
vs
kit
fals
posit
result
may
hypothet
relat
fact
techniqu
includ
opentub
post
amplif
step
potenti
associ
increas
risk
pcr
contamin
serial
dilut
test
inf
inf
b
inf
c
hmpv
pathogen
detect
concentr
dilut
test
neg
dilut
fig
studi
global
confirm
previous
observ
good
perform
xtag
respiratori
viral
panel
fast
core
test
global
sensit
specif
valu
respect
tabl
poorest
result
observ
influenza
posit
predict
valu
influenza
b
human
bocaviru
sensit
valu
respect
serial
dilut
test
pathogen
detect
concentr
dilut
one
hmpv
test
neg
dilut
inf
b
hrsv
hrsv
b
hmpv
dilut
fast
track
diagnost
respiratori
pathogen
kit
perform
well
core
test
global
sensit
specif
valu
tabl
excel
specif
valu
highest
panel
test
may
relat
part
simpl
safe
realtim
pcr
format
techniqu
requir
postpcr
manipul
amongst
core
test
agreement
previou
find
lowest
sensit
valu
observ
human
respiratori
syncyti
viru
enterovirusrhinoviru
respect
serial
dilut
test
pathogen
detect
concentr
dilut
inf
b
c
hrsv
b
test
neg
dilut
inf
b
c
hrsv
b
ev
cox
hpev
hadv
b
hmpv
dilut
coher
previou
observ
respifind
smart
assay
provid
core
test
highest
youden
index
perform
valu
global
core
test
youden
index
valu
best
global
sensit
also
associ
excel
specif
agreement
previou
evalu
amongst
core
test
lowest
sensit
valu
observ
human
metapneumoviru
kit
also
provid
best
result
serial
dilut
test
pathogen
detect
concentr
dilut
test
posit
dilut
hmpv
test
neg
dilut
present
studi
identifi
high
degre
correl
least
three
techniqu
complet
overview
multiplex
techniqu
avail
diagnosi
acut
respiratori
infect
kit
evalu
perform
properli
core
test
youden
index
posit
predict
specif
valu
systemat
higher
core
test
extra
test
signific
differ
abil
kit
detect
low
viral
load
identifi
medic
implic
observ
remain
evalu
rang
detect
pathogen
technolog
use
pcr
product
revel
laboratori
organ
issu
sampl
throughput
staf
level
staff
expertis
clinician
support
inform
file
pcr
confirm
assay
core
test
tabl
extratest
tabl
b
docx
